|
1
|
Lagergren J, Smyth E, Cunningham D and
Lagergren P: Oesophageal cancer. Lancet. 390:2383–2396. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lakshminarayana S, Augustine D, Rao RS,
Patil S, Awan KH, Venkatesiah SS, Haragannavar VC, Nambiar S and
Prasad K: Molecular pathways of oral cancer that predict prognosis
and survival: A systematic review. J Carcinog. 17:72018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarode GS, Sarode SC, Maniyar N, Anand R
and Patil S: Oral cancer databases: A comprehensive review. J Oral
Pathol Med. 47:547–556. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Meng X, Zhu XW, Yang DC, Chen R,
Jiang Y and Xu T: Long non-coding RNAs in Oral squamous cell
carcinoma: Biologic function, mechanisms and clinical implications.
Mol Cancer. 18:1022019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomes CC, de Sousa SF, Calin GA and Gomez
RS: The emerging role of long noncoding RNAs in oral cancer. Oral
Surg Oral Med Oral Pathol Oral Radiol. 123:235–241. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang F, Li J, Xiao H, Zou Y, Liu Y and
Huang W: AFAP1-AS1: A novel oncogenic long non-coding RNA in human
cancers. Cell Prolif. 51:e123972018. View Article : Google Scholar
|
|
12
|
Zhang K, Liu P, Tang H, Xie X, Kong Y,
Song C, Qiu X and Xiao X: AFAP1-AS1 promotes epithelial-mesenchymal
transition and tumorigenesis through wnt/beta-catenin signaling
pathway in triple-negative breast cancer. Front Pharmacol.
9:12482018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang XD, Zhang DD, Jia L, Ji W and Zhao
YS: lncRNA AFAP1-AS1 promotes migration and invasion of non-small
cell lung cancer via Up-regulating IRF7 and the RIG-I-like receptor
signaling pathway. Cell Physiol Biochem. 50:179–195. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lian Y, Xiong F, Yang L, Bo H, Gong Z,
Wang Y, Wei F, Tang Y, Li X, Liao Q, et al: Long noncoding RNA
AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to
facilitate nasopharyngeal carcinoma metastasis through regulating
the Rho/Rac pathway. J Exp Clin Cancer Res. 37:2532018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang J, Zhong G, Wu J, Chen H and Jia Y:
Long noncoding RNA AFAP1-AS1 facilitates tumor growth through
enhancer of zeste homolog 2 in colorectal cancer. Am J Cancer Res.
8:892–902. 2018.PubMed/NCBI
|
|
16
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo JQ, Li SJ and Guo GX: Long noncoding
RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric
cancer cells via PTEN/p-AKT pathway. Dig Dis Sci. 62:2004–2010.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geng YD, Wang SB, Lu TQ and Teng W:
Expression and functions of long non-coding RNA actin
filament-associated protein 1-antisense RNA1 in oral squamous cell
carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi. 37:594–601. 2019.(In
Chinese). PubMed/NCBI
|
|
19
|
Ding J, Sun D and Xie P: Elevated
microRNA-145 inhibits the development of oral squamous cell
carcinoma through inactivating ERK/MAPK signaling pathway by
down-regulating HOXA1. Biosci Rep. 39:BSR201822142019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Li XD, Fu Z, Zhou Y, Huang X and
Jiang X: Long noncoding RNA LINC00473/miR195-5p promotes glioma
progression via YAP1-TEAD1-Hippo signaling. Int J Oncol.
56:508–521. 2020.PubMed/NCBI
|
|
22
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
24
|
Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F,
Qing X, Liu J, Zhang Z and Shao Z: LncRNA AFAP1-AS1 promotes
tumorigenesis and epithelial-mesenchymal transition of osteosarcoma
through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin
Cancer Res. 38:3752019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu WX, Liu Z, Deng F, Wang DD, Li XW, Tian
T, Zhang J and Tang JH: MiR-145: A potential biomarker of cancer
migration and invasion. Am J Transl Res. 11:6739–6753.
2019.PubMed/NCBI
|
|
27
|
Zeinali T, Mansoori B, Mohammadi A and
Baradaran B: Regulatory mechanisms of miR-145 expression and the
importance of its function in cancer metastasis. Biomed
Pharmacother. 109:195–207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shao Y, Qu Y, Dang S, Yao B and Ji M:
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by
targeting c-Myc and Cdk6. Cancer Cell Int. 13:512013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao L, Ren W, Chang S, Guo B, Huang S, Li
M, Guo Y, Li Z, Song T, Zhi K and Huang C: Downregulation of
miR-145 expression in oral squamous cell carcinomas and its
clinical significance. Onkologie. 36:194–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bufalino A, Cervigne NK, de Oliveira CE,
Fonseca FP, Rodrigues PC, Macedo CC, Sobral LM, Miguel MC, Lopes
MA, Paes Leme AF, et al: Low miR-143/miR-145 cluster levels induce
activin a overexpression in oral squamous cell carcinomas, which
contributes to poor prognosis. PLoS One. 10:e01365992015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Liu J and Lu X: HOXA1 upregulation
is associated with poor prognosis and tumor progression in breast
cancer. Exp Ther Med. 17:1896–1902. 2019.PubMed/NCBI
|
|
32
|
Zhang Y, Li XJ, He RQ, Wang X, Zhang TT,
Qin Y, Zhang R, Deng Y, Wang HL, Luo DZ and Chen G: Upregulation of
HOXA1 promotes tumorigenesis and development of nonsmall cell lung
cancer: A comprehensive investigation based on reverse
transcription-quantitative polymerase chain reaction and
bioinformatics analysis. Int J Oncol. 53:73–86. 2018.PubMed/NCBI
|
|
33
|
Bitu CC, Destro MF, Carrera M, da Silva
SD, Graner E, Kowalski LP, Soares FA and Coletta RD: HOXA1 is
overexpressed in oral squamous cell carcinomas and its expression
is correlated with poor prognosis. BMC Cancer. 12:1462012.
View Article : Google Scholar : PubMed/NCBI
|
